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Abstract
Background: The term “Transient Warming Events” (TWE) has been used to describe the
effects of brief periods of exposure of cryopreserved cells to ambient temperature in the course of
retrieving and returning outgoing samples from the same cane. This study was designed to
evaluate the effect of multiple TWEs on cryogenically preserved umbilical cord blood units
(UCB) at the New Jersey Community Blood Centre using established assays of cell recovery,
viability, and clonogenicity.
Materials and methods: The UCBs were collected and processed according to the laboratory
SOPs from consenting donors. Each UCB was split into two 25 mL samples: an experimental
and a control sample. Both samples were frozen using a Controlled Rate Freezer and then
stored below –180°C in the vapour phase of a liquid nitrogen (LN2) freezer. The experimental
samples were exposed 10 times to room temperature until the sample reached a target tempera-
ture. We tested target temperatures of –110°C and –80°C. Finally, both experiment and control
samples were simultaneously thawed in a 37°C dry bath. Each sample was tested for Total
Nucleated Cell (TNC) count, CD34+ cell count, cell viability, and ability to generate Colony
Forming Units (CFU) in a standardized assay.
Results: When UCB units were each exposed to 10 TWE to a target temperature of –110°C,
analysis of cell counts showed a 1.5% loss of TNC, 3.5% loss of CD34+ cells, and 2% drop in
CFU, with no loss of viability. None of the values between experimental and control was statistical-
ly significant. When UCB units were exposed to 10 TWE to a target temperature of –80°C, the
differences between experimental and control samples in the TNC, CD34+ cell count and viability
were also not statistically significant. The numbers of CFUs in experimental samples was de-
creased by 8% compared to control, and reached statistical significance. In the New Jersey Commu-
nity Blood Centre, removal of a UCB from cryogenic storage takes less than a minute to execute,
typical of other UCB storage centres with well planned and executed sample retrieval protocols. It
would take three times as long for a 25 ml UCB to reach a target temperature of –110°C, and five
times as long to reach a target temperature of –80°C. We found no significant degradation of cell
function after repeated TWE to target temperatures as high as –110°C.
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Conclusions: The results of this study demonstrate that the TWE that UCB units experience
in day-to-day sample retrieval activities are not detrimental to the samples that are returned
repeatedly to cryogenic storage at the New Jersey Community Blood Centre. This should
encourage other centres to conduct their own TWE studies to evaluate the effects of TWEs with
each type of cryopreserved tissue and associated methods of storage and retrieval, before con-
sidering investing in highly expensive cryostorage units that are designed to minimize TWEs.
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Streszczenie
Wstęp: Określenie Transient Warming Events (TWEs) oznacza krótkie okresy ekspozycji
zamrożonych komórek na temperaturę otoczenia, w trakcie rutynowych czynności laboratoryj-
nych. Celem pracy była ocena wpływu wielokrotnych TWEs na wybrane parametry zamrożo-
nych jednostek krwi pępowinowej (UCB) przechowywanych w New Jersey Community Blood
Center (NJCBC). Wykorzystano znane metody oceny i odzysku komórek, ich żywotności
i zdolności klonogennych.
Materiał i metody: Jednostki UCB pobierano za zgodą dawców i poddawano preparatyce
zgodnie z obowiązującymi procedurami (SOP, standard operating procedures). Każdą z nich
dzielono na dwie 25-mililitrowe próbki, mrożono w urządzeniu  do kontrolowanego zamraża-
nia i przechowywano < –180°C. Próbki badane poddawano 10-krotnej ekspozycji na tempera-
turę pokojową, aż do uzyskania temperatur docelowych (–110°C , –80°C). Próbki kontrolne
przechowywano w stałej temperaturze poniżej –180°C. Następnie próbki badane i kontrolne
rozmrażano równocześnie w urządzeniu do suchego rozmrażania w temperaturze 37°C.
W każdej próbce oceniano całkowitą liczbę komórek jądrzastych (TNC, total nucleated cell
count), liczbę komórek CD34+, żywotność komórek oraz liczbę jednostek tworzących kolonie
(CFU, colony forming units).
Wyniki: W próbkach poddanych 10-krotnemu działaniu temperatury pokojowej aż do osią-
gnięcia docelowej temperatury –110°C stwierdzono 1,5-procentowe zmniejszenie TNC,
3,5-procentowe zmniejszenie liczby  komórek CD34+ oraz 2-procentowe zmniejszenie  całko-
witej  liczby CFU. Nie zaobserwowano strat w żywotności komórek. Różnice między próbkami
badanymi a kontrolnymi w zakresie badanych parametrów nie były statystycznie istotne.
Różnice pomiędzy  próbkami badanymi poddanymi 10-krotnemu działaniu temperatury poko-
jowej, aż do osiągnięcia temperatury –80°C a próbkami kontrolnymi  również  nie były staty-
stycznie istotne pod względem liczby TNC, liczby komórek CD34+ i żywotności; całkowita
liczba CFU w próbkach badanych była niższa o 8%, co było  statystycznie istotne.  W NJCBC
jednorazowa ekspozycja jednostek UCB na temperaturę pokojową nie przekracza 1 min,
a uzyskanie temperatury –110°C trwa około 3,5 minuty. 
Wnioski: Wyniki naszych badań wykazują, że wielokrotna, kontrolowana ekspozycja zamro-
żonych jednostek UCB w trakcie rutynowych czynności laboratoryjnych, nie wywiera szkodli-
wego wpływu na jakość biologiczną  preparatów.  Uzyskane przez nas wyniki powinny zachę-
cić inne ośrodki do prowadzenia własnych badań nad wpływem TWE na jakość poszczegól-
nych  rodzajów komórek przechowywanych w stanie zamrożenia oraz stosowanych metod
zamrażania i rozmrażania. Dopiero wówczas można podejmować decyzje o zakupie wysoce
specjalistycznego sprzętu chłodniczego z zamiarem obniżenia liczby TWE.
Słowa kluczowe: krew pępowinowa, mrożenie, krótkie okresy ekspozycji na temperaturę
pokojową
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Umbilical Cord Blood (UCB) is an attractive
source of Haematopoietic Progenitor Cells (HPC).
Its many advantages over bone marrow-derived
HSCs include its almost immediate availability, low
cost, and reduced HLA matching stringency [1, 2].
If prospectively tested and HLA confirmed, they can
be delivered within 24–48 hours to any transplant
centre in the world. Recent information indicates
that UCBs are now chosen more often than Bone
Marrow HSCs, and have become the second most
popular source of HPC for required patient haema-
tological reconstitution.
Current qualification criteria are based on mi-
nimum Nucleated Cell dose/kg [3], CD 34+ cell
dose/ kg [4], and cell viability. Transplant physicians
are making the decision based on the data collec-
ted before freezing and presented by processing
laboratory.
In many instances transplant centres report
a significant discrepancy between pre-freezing and
post-thaw results of UCB units delivered. There
may be many reasons behind low cell recovery and
cell viability after thawing. Cryopreservation is the
best method of long-term storage for HPC; howe-
ver, storage conditions and sample handling can play
a significant role in final cell quality.
It is postulated that Transient Warming Events
(TWE) may have an adverse effect on cell quality.
This phenomenon was first introduced by Dobrila
et al. (“Transient Warming Events and Cell Viabi-
lity of Placental/Umbilical Cord Blood” presented
at the ISHAGE, Quebec, Canada and the 5th Tokyo
International Symposium on Cord Blood Transplan-
tation in Tokyo, Japan. The results of these studies
have been published online http://www.thermoge-
nesis.com/CMSFiles/Pdf/Clinical/bmtposter.pdf.
The authors suggest that TWE is associated
with the Glass Transition temperature (Tg) and that
multiple exposures to TWE significantly affect cell
viability and function. Bellow Tg temperature, mo-
lecules lose their mobility [5], which means that no
damage to the cells should be observed. To mini-
mize damage to the cell structure, samples should
be stored approximately 20°C below the Tg [5].
According to some studies Tg is observed betwe-
en –128 and –143°C [6]. Some other studies by
Velikov [7] and Giovambattista at al. [8] suggest that
true Tg occurs at around –103–108°C.
Unfortunately, in traditional freezers, cells are
exposed multiple times (5–6) to ambient tempera-
ture when transferred from one freezer to another.
1. Transferring UCBs from a Controlled Rate
Freezer to a Quarantine Freezer
2. Transferring UCBs from a Quarantine Freezer
to a Permanent Storage Freezer
3. Removing a segment for HLA confirmatory
typing
4. Transferring UCBs from the freezer to an LN2
dry shipper
5. Transferring UCBs from a dry shipper to a tem-
porary freezer at a Transplant Centre
6. Thawing the unit.
In addition, units that are stored in racks sha-
red by multiple units can be exposed to TWE mul-
tiple times when other samples are accessed.
We decided to evaluate the effect of such
events and calculate the potential risk of multiple
exposures on in vitro cell quality after thawing.
Material and methods
Collection and processing
Eighteen Umbilical Cord Blood units (UCB)
were collected according to our laboratory’s SOP,
with appropriate NMDP donor consent. Blood was
collected into 250 mL collection bags (Baxter, IL)
containing 35 mL of CPD. After UCB qualification,
a calculated volume of Hydroxy Ethyl Starch (HE-
SPAN; Braun Medical Inc. CA) was added to the
collection bag that was then sterile docked (TCD
B40, Haemonetics Corp. MA) with Processing Kit
530 (Biosafe, Switzerland). Cell separation was
done using a Sepax AS-210 (Biosafe, Switzerland).
Following cell separation (35–45 min) the volume
of each unit was adjusted to 40 mL using autologo-
us plasma. 10 mL of 55% DMSO and 5% Dextran
40 (CryoSure-Dex40, WAK-Chemie Medical
GmbH, Germany) was then aspirated to a syringe,
connected to a processing bag and slowly added
(0.5 mL/minute) using an 11 Plus syringe pump
(Harvard Apparatus, MA). Each sample was then
split into two 25 mL portions, transferred to a fre-
ezing container (Pall Medical, NY), placed in metal
canisters, and then frozen using a Controlled Rate
Freezer (CryoMed, Thermo Electron Corp., OH).
When the samples reached –90°C, the bags were
transferred to a V3000 Isotherm LN2 freezer (Cu-
stom BioGenic System, MI) and then stored for
3–8 months below –180°C in the vapour phase of
liquid nitrogen.
Bags designated for –110oC (10 UCB pairs) or
–80°C (8 UCB pairs) were placed in one rack (A)
and the control pair samples in another rack (B).
One of the cassettes in rack A was opened and
a thermocouple was placed on the surface of the UCB.
Just before rack A was removed from storage to
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a room temperature, the thermocouple was connec-
ted to an Omegaette HH306 data logger (Omega,
CT) and activated to observe and record tempera-
ture changes. Each UCB in rack A remained at room
temperature until the temperature of the UCB re-
ached the target temperature, at which point rack
A was promptly returned to the LN2 vapour freezer.
It took approximately 3.5 minutes for the surface
of the cryopreserved UCB to reach –110°C, whe-
reas to reach –80°C it took approximately 6.5 mi-
nutes. One of the samples from each UCB was expo-
sed to ambient temperature until the temperature
of the samples reached either –110°C or –80°C and
was then returned to the LN2 freezer.
Data representing one of ten TWEs when sam-
ples in rack A were warmed to –80°C is shown in
Figure 1. Control samples in rack B remained in the
vapour phase of LN throughout the whole experi-
ment. This procedure was repeated 10 times eve-
ry 24 hours on the same 18 samples before all
36 samples were thawed in a 37°C dry bath Cyto-
Therm D1 (CytoTherm, NJ). Samples were thawed
in pairs, one pair at a time. Once thawed, the sam-
ples were sampled and assessed for Total Nucleated
Cell (TNC) count, CD34+ cell count, cell viability,
and ability to generate Colony Forming Units (CFU).
Testing
Whole Blood Cell (WBC) count was performed
using Sysmex XE-2100 (Sysmex, Japan). The TNC
was calculated by multiplying the WBC by the UCB
total volume.
The CD34+ cell assay and cell viability were
obtained using dual platform ISHAGE protocol and
FACScalibur (BD Bioscience, CA) flow cytometer.
Monoclonal antibodies used in the CD34+ assay
include anti-CD34 and anti-CD45. The cell viabili-
ty was established using 7-Amino-actinomycin D
(7-AAD) . The CFU assay was performed using Me-
thoCult GF H4434 (Stem Cell Technologies, Cana-
da). Twenty-five thousand Nucleated Cells were
seeded on each of three dishes. Then they were
incubated at 37°C and 95% humidity for 14 days.
After 14 days three types of colonies were coun-
ted: BFU-E, CFU-GM and CFU-GEMM.
Statistics
Paired student’s test was used to show whe-
ther there was a statistical significant difference
between the test set of data and the control set of
data.
Results
The first set of experiments when samples in
rack A were warmed to –110°C showed small diffe-
rences between tested and controlled samples.
Average time to warm to —110°C was 3.5 minu-
tes. The TNC was reduced by 1.5%. The total num-
ber of CD34+ cells was 3.5% below the control, and
total number of CFU’s was only 2% lower. Viabili-
ty of the cells tested the same. All differences were
not statistically significant.
Because of the lack of significant effects of
TWE in the first set of experiments, the experi-
ments were repeated, only this time the samples
were warmed to -80°C. This process took on ave-
rage 6.5 minutes. This time three out of four me-
asured parameters were not statistically different.
The only difference was observed in Total CFU,
which was 8.5% lower in samples exposed to TWE
when compared to their own controls stored in the
vapour phase of LN2 during the whole study. Clo-
ser analysis of different forms of colonies showed
that the only difference was observed in numbers
of BFU-E population. The other colonies of CFU-
-GM and CFU-GEMM remained not statistically si-
gnificant.
Discussion
There is no question that the handling of bio-
logical tissue like UCB cells for the long term in LN2
freezers may have some effect on post-thawing cell
quality and consequently have an impact on post-
transplantation bone marrow reconstitution. Tran-
Figure 1. Warming and freezing curve of one event;
sample warmed to –80°C. Similar graphs were obtained
in the course of study for every sample used in the pro-
ject and exposed 10 times to the ambient temperature
Rycina 1. Krzywa ogrzania i ponownego zamrażania
preparatow do temperatury –80°C. Podobne wykresy
uzyskano dla każdego preparatu w trakcie eksperymen-
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sient warming events are associated with morpho-
logical changes of ice at the so-called glass transi-
tion temperature. Many studies suggest that this
is observed around –135°C; however, there are
other studies suggesting that the Tg happened at
around –108°C [7, 8]. The change of ice property at
the Tg temperature can potentially affect cell via-
bility. The multiple exposures that occur in every
laboratory can accelerate this process. There has
been little published data to determine whether
multiple excursions through the Tg temperature
have an effect on cells that can be considered rele-
vant to their desired functional therapeutic efficacy.
Our first step was to test the hypothesis that
multiple events of transient warming could reveal
symptoms of adverse reaction. Two identical sam-
ples were prepared from one unit and stored in the
vapour phase of LN2 for at least three months. One
sample was then repeatedly exposed to room tempe-
rature to allow the sample surface warm to —110°C.
After 10 events, both control and test samples
were thawed simultaneously and evaluated.
To our surprise we did not observe any eviden-
ce of cell deterioration. Small changes in all tested
parameters were not statistically significant. This
very important observation leads us to the conclu-
sion that Tg may occur at a higher temperature than
–135°C. Based on the studies of Velikov [7] and
Giovambattist [8], Tg is observed at –108°C. This
could potentially explain why we did not observe
any changes in cell quality in our first study. To
address this question, we tested these same para-
meters using this same protocol but warming our
experimental UCBs to -80°C. The second set of stu-
Table 1. Quality results for 10 products following 10 exposures to ambient temperatures until the sample
reached –110oC. Results presented as Mean ± 1 Standard Deviation
Tabela 1. Parametry jakości dla 10 preparatów po 10 ekspozycjach na temperaturę otoczenia, do momentu
ogrzania preparatu do –110oC. Wyniki przedstawiono jako średnią ± 1 odchylenie standardowe
Final temperature Control UCB not UCB expose Student’s t test
–110°C expose TWE 10 times to TWE
N = 10
TNC (× 106 cells) Range 579–793 Range 562–799 0.41 ns
Mean 649.95 ± 74.23 Mean 640.50 ± 71.74
CD34 (× 106 cells) Range 1.01–3.65 Range 0.83–3.71 0.73 ns
Mean 1.92 ± 0.84 Mean 1.85 ± 0.94
Viability (%) Range 73–90 Range 73–91 0.53 ns
Mean 82.40 ± 5.62 Mean 62.40 ± 5.62
Total CFU (× 106 cells)* Range 0.180–0.867 Range 0.158–0.895 0.61 ns
Mean 0.449 ± 0.249 Mean 0.441 ± 0.253
NS — not statistically significant; *n = 9: CFU analysis was available only for 9 samples
Table 2. Quality results for 8 products following 10 exposures to ambient temperatures until the sample
reached –80oC. Results presented as Mean ± 1 Standard Deviation
Tabela 2. Parametry jakości dla 8 preparatow po 10 ekspozycjach na temperaturę otoczenia do momentu
ogrzania preparatu do –80oC . Wyniki przedstawiono jako średnią ± 1 odchylenie standardowe
Final Temperature Control UCB Not UCB Exposed Student’s t-test
–80°C Exposed to TWE 10 times to TWE
n = 8
TNC (× 106 cells) Range 295–646 Range 303–656 0.54 (NS)
Mean 474.83 ± 131.07  Mean 481.78 ± 130.51
CD34 (× 106 cells) Range 0.71–3.25 Range 0.69–3.17 0.55 (NS)
Mean 1.32 ± 0.83 Mean 1.29 ± 0.80
Viability % Range 73–90 Range 83–90 0.11 (NS)
Mean 89.88 ± 6.75 Mean 91.25 ± 5.65
Total CFU (× 106 cells) Range 0.157–0.819 Range 0.109–0.657 (p < 0.05)
Mean 0.366 ± 0.211 Mean 0.308 ± 0.191
NS — not statistically significant
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dies required longer time exposure (about 6.5 min)
to warm up the surface of the sample to –80°C.
This time the changes in TNC and Total CD34+
as well as in cell viability were not statistically si-
gnificant. However, a significant drop in total CFUs
of about 8.5% was observed. The results of these two
experiments suggest that the real Tg is either lower
than –135°C or that excursion of the cells through
the Tg range does not significantly affect any of the
parameters measured in this study. Irrespective of
the explanation, our data indicates that we can put
quite reasonable limitations on the time and num-
ber of transfers of UCB in and out of the LN2 cry-
opreservation during normal daily operations of our
cord blood bank without causing damage to the cells.
Well organized and planned storage and appro-
priate training of laboratory employees at the New
Jersey Community Blood Centre results in expo-
sure of UCB to ambient temperatures for much less
than 3.5 minutes. In our laboratory we try to redu-
ce the time when UCB units are exposed to room
temperature, and most of the manipulations, like
taking a segment of the bag or inspecting the ID
before shipping the unit to transplant centre, are
carried inside the vapour LN2 freezer. From our
experience, each manipulation takes less than one
minute, which, based on our study, warms the sam-
ple to –160 ± 5°C.
In summary, we believe that it is important to
properly train laboratory personnel how to handle
cryopreserved samples and make them understand
the consequences of TWE. Multiple warm up abo-
ve the Tg temperature will affect cell quality and
may cause a lack of engraftment after transplanta-
tion. Although our TWE experiments to -80°C de-
monstrated that even excursions through the Tg
had little, if any effect on sample integrity, based
on documented studies of glass transition tempe-
ratures it is nonetheless wise to avoid multiple
excursions around a temperature of approximately
–108°C. This is clearly not a significant issue for our
facility. Our study results should encourage other
centres to conduct their own TWE studies to eva-
luate the effects of TWEs with each type of cryopre-
served tissue and associated methods of storage and
retrieval, before considering investing in highly
expensive cryostorage units that are designed to
minimize TWEs.
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